Clinical Trial Update: Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term safety and tolerability of mesalamine pellets in participants with ulcerative colitis in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• mesalamine pellets (mesalamine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2019-11-01